| | 508233-74-7 Basic information More.. |
| Product Name: | Vortioxetine | | Synonyms: | Trintellix (vortioxetine);Vortioxetine(Lu AA21004);1-(2-((2,4-DIMETHYLPHENYL)THIO)PHENYL)PIPERAZINE-HCL;Vortioxetin;Vortioxetine, >=99%;Vortioxetine ?LuAA21004 ? 1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine;Lu AA 21004;Vortioxetine | | CAS: | 508233-74-7 | | MF: | C18H22N2S | | MW: | 298.45 | | EINECS: | 823-919-6 | | Mol File: | 508233-74-7.mol |  |
Use
Vortioxetine is a new drug for treating depression, jointly developed and researched by the Danish Lundbeck (Lundbeck) and Japanese Takeda. In September 30, 2013, It is approved by the U.S. Food and Drug Administration (FDA) to enter into market with the brand name of Brintellix, for Major Depression Disorder (MDD) treatment.Takedas Trintellix (vortioxetine hydrobromide) 5mg, 10mg and 20mg tablets lose their US new chemical entity (NCE) data exclusivity at the end of September 2018. The brand-name change to Trintellix came into effect in May 2016 to decrease the risk of prescribing and dispensing errors due to name confusion with AstraZeneca’s antiplatelet drug Brilinta (ticagrelor).
- Vortioxetine
-
- US $2.00 / kg
- 2025-09-04
- CAS:508233-74-7
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100KG/M
- Vortioxetine
-
- US $0.00 / kg
- 2025-09-04
- CAS:508233-74-7
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 1000kg
- Vortioxetine
-
- US $43.00-87.00 / mg
- 2025-09-03
- CAS:508233-74-7
- Min. Order:
- Purity: 99.82%
- Supply Ability: 10g
|
|
508233-74-7
Recommend Suppliers |
|